Brakenridge, Christian J. http://orcid.org/0000-0001-6022-7539
Koster, Annemarie http://orcid.org/0000-0003-1583-7391
de Galan, Bastiaan E. http://orcid.org/0000-0002-1255-7741
Carver, Alison http://orcid.org/0000-0001-5166-3574
Dumuid, Dorothea http://orcid.org/0000-0003-3057-0963
Dzakpasu, Francis Q. S. http://orcid.org/0000-0002-5536-0199
Eussen, Simone J. P. M. http://orcid.org/0000-0003-0559-6838
Savelberg, Hans H. C. M. http://orcid.org/0000-0002-8864-2109
Bosma, Hans http://orcid.org/0000-0003-4333-4564
Owen, Neville http://orcid.org/0000-0003-2784-4820
Schaper, Nicolaas C. http://orcid.org/0000-0002-2128-8029
Healy, Genevieve N. http://orcid.org/0000-0001-7093-7892
Dunstan, David W. http://orcid.org/0000-0003-2629-9568
Funding for this research was provided by:
Cilag
Sanofi
European Regional Development Fund
Australian Research Council (DE230101174)
Novo Nordisk
National Health and Medical Research Council (Fellowships scheme, MRFF Emerging Leadership Investigator Grant (#1193)
Swinburne University of Technology
Article History
Received: 30 November 2023
Accepted: 28 February 2024
First Online: 24 April 2024
Acknowledgements
: We acknowledge the people who participated in this study, without whom this work would not be possible. Preliminary analyses of these data appear in a PhD thesis by CJB.
: Datasets generated and analysed are not publicly available but are available from the corresponding author upon reasonable request.
: The Maastricht Study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 31O.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), the Cardiovascular Center (CVC, Maastricht, the Netherlands), CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands), CAPHRI Care and Public Health Research Institute (Maastricht, the Netherlands), NUTRIM School for Nutrition and Translational Research in Metabolism (Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands), and by unrestricted grants from Janssen-Cilag BV (Tilburg, the Netherlands), Novo Nordisk Farma BV (Alphen aan den Rijn, the Netherlands), and Sanofi-Aventis Netherlands BV (Gouda, the Netherlands). DD was funded by an Australian Research Council (ARC) Discovery Early Career Award (DE230101174). DWD and NO are supported by the NHMRC Fellowships scheme and the Victorian Government’s OIS Program. GNH was supported by an MRFF-NHMRC Emerging Leadership Investigator Grant (no. 1193815). The funders of this study and The Maastricht Study were not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; and did not impose any restrictions regarding the publication of the report.
: BEdG is a member of the editorial board of <i>Diabetologia</i>. The remaining authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
: CJB contributed to the conception and design, analysed, and interpreted data, drafted and revised the manuscript critically for important intellectual content. DWD, GNH, NO, AC and FQSD were involved in the conception of the study design, drafted, and revised the manuscript critically for important intellectual content. DD made substantial contributions to the analysis and interpretation of the data, and reviewed the text critically for important intellectual content. AK, BEdG and NCS provided substantial contributions to the conception of the design, acquisition of the data, and provided critical review and drafting of the manuscript. SJPME, HHCMS and HB provided substantial contributions to the acquisition of the data and provided critical review for important intellectual content. All authors provided final approval of the version to be published. DWD is the guarantor of this work.